Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors

被引：17
|
作者：
Imamovic, Denira [1 ]
Vranic, Semir [1 ,2 ,3 ]
机构：
[1] Univ Sarajevo, Sch Med, Sarajevo, Bosnia & Herceg
[2] Univ Sarajevo, Clin Ctr, Dept Pathol, Sarajevo, Bosnia & Herceg
[3] Qatar Univ, Coll Med, Doha, Qatar
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2017年 / 5卷 / 23期
关键词：
SOLID TUMORS; ACQUIRED-RESISTANCE; BLOCKADE; IMMUNOTHERAPY; MUTATIONS; MELANOMA;
D O I：
10.21037/atm.2017.09.32
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
    Sun, Chong
    Mezzadra, Riccardo
    Jae, Lucas T.
    Gomez-Eerland, Raquel
    de Vries, Evert
    Wu, Wei
    Xiao, Yanling
    Heck, Albert J.
    Borst, Jannie
    Brummelkamp, Thijn R.
    Schumacher, Ton N.
    CANCER RESEARCH, 2017, 77
  • [2] Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
    Riccardo Mezzadra
    Chong Sun
    Lucas T. Jae
    Raquel Gomez-Eerland
    Evert de Vries
    Wei Wu
    Meike E. W. Logtenberg
    Maarten Slagter
    Elisa A. Rozeman
    Ingrid Hofland
    Annegien Broeks
    Hugo M. Horlings
    Lodewyk F. A. Wessels
    Christian U. Blank
    Yanling Xiao
    Albert J. R. Heck
    Jannie Borst
    Thijn R. Brummelkamp
    Ton N. M. Schumacher
    Nature, 2017, 549 : 106 - 110
  • [3] Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
    Mezzadra, Riccardo
    Sun, Chong
    Jae, Lucas T.
    Gomez-Eerland, Raquel
    de Vries, Evert
    Wu, Wei
    Logtenberg, Meike E. W.
    Slagter, Maarten
    Rozeman, Elisa A.
    Hofland, Ingrid
    Broeks, Annegien
    Horlings, Hugo M.
    Wessels, Lodewyk F. A.
    Blank, Christian U.
    Xiao, Yanling
    Heck, Albert J. R.
    Borst, Jannie
    Brummelkamp, Thijn R.
    Schumacher, Ton N. M.
    NATURE, 2017, 549 (7670) : 106 - +
  • [4] CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
    Zhang, Tong
    Yu, Haixiang
    Dai, Xiangpeng
    Zhang, Xiaoling
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
    Takeuchi, Hiroto
    Konnai, Satoru
    Maekawa, Naoya
    Minato, Erina
    Ichikawa, Yoshiki
    Kobayashi, Atsushi
    Okagawa, Tomohiro
    Murata, Shiro
    Ohashi, Kazuhiko
    FRONTIERS IN VETERINARY SCIENCE, 2020, 7
  • [6] Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
    Xue, Hui
    Qiu, Bin
    Wang, Hao
    Jiang, Ping
    Zhang, Weiwei
    Xue, Lixiang
    Wang, Junjie
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (08) : 1193 - 1196
  • [7] CMTM6 controls PD-L1
    Ioana Visan
    Nature Immunology, 2017, 18 : 1067 - 1067
  • [8] CMTM6, the New PD-L1 Regulator, Correlates with PD-L1 Expression in Lung Cancer
    Gao, Feng
    Li, Jun
    Chu, Heidi
    Chen, Jing
    LABORATORY INVESTIGATION, 2019, 99
  • [9] CMTM6 controls PD-L1
    Visan, Ioana
    NATURE IMMUNOLOGY, 2017, 18 (10) : 1067 - 1067
  • [10] CMTM6, the New PD-L1 Regulator, Correlates with PD-L1 Expression in Lung Cancer
    Gao, Feng
    Li, Jun
    Chu, Heidi
    Chen, Jing
    MODERN PATHOLOGY, 2019, 32
12345